secwatch.observer — SEC 8-K summary
======================================

Issuer:     Silo Pharma, Inc. (SILO)
CIK:        0001514183
Form:       8-K12B
Filed at:   2023-12-20T23:59:59+00:00
Accession:  0001213900-23-097364
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Silo Pharma reincorporates from Delaware to Nevada, effective December 19, 2023
-------------------------------------------------------------------------------

- Reincorporation completed via Plan of Conversion approved by stockholders on Dec 4/11, 2023.
- Each outstanding share of Delaware common stock converted one-for-one into Nevada common stock.
- Options, warrants, and equity plans continue on same terms; no exchange of stock certificates required.
- Ticker remains SILO on Nasdaq; business, management, and offices unchanged.
- Stockholder rights now governed by Nevada law; differences detailed in Oct 23, 2023 proxy statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023097364/0001213900-23-097364-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1514183/000121390023097364/ea190371-8k12b_silopharma.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-097364

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer